Back
PepGen Inc. PEPG · Insights
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the t... Price2.39
Market Cap167.72 M
Float54.52 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro